MAPT and Alzheimer disease: Zetterberg et al. (2013) applied a single molecule array (SimoaTM) assay to quantitatively evaluate the total tau protein level in plasma and found that the plasma tau protein concentration of AD patients is higher than those of MCI patients and normal controls.